SSI(SZ:002742)2025-01-17 14:15Financial Performance Expectations - The company expects a net loss for 2024 between CNY 46 million and CNY 66 million, compared to a net loss of CNY 45.20 million in the same period last year[3]. - The projected operating revenue for 2024 is estimated to be between CNY 115 million and CNY 135 million, down from CNY 203.02 million in the previous year[3]. - The expected net loss after deducting non-recurring losses is projected to be between CNY 57 million and CNY 77 million, compared to a loss of CNY 42.69 million last year[3]. Factors Affecting Performance - The decline in performance is primarily attributed to significant decreases in the domestic building materials and pharmaceutical sectors[5]. - The overseas business has been negatively impacted by currency depreciation[5]. - Increased financial expenses due to overdue debts have also contributed to the expected losses[5]. Financial Reporting and Audit - The financial data in the earnings forecast has not been audited by the accounting firm[4]. - The company has communicated with the accounting firm regarding the earnings forecast, and there are no discrepancies[4]. - Detailed financial data will be disclosed in the 2024 annual report, and investors are advised to pay attention to investment risks[6]. - This earnings forecast is based on preliminary calculations by the company's finance department[6].